---
title: "MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290055475.md"
description: "A biotechnology company called MetaVia Inc., which focuses on transforming cardiometabolic diseases, revealed that its President and CEO, Hyung Heon Kim, is set to take part in a fireside chat. The company made this announcement today in Cambridge, Mass., dated June 17, 2026. MetaVia Inc. is listed on Nasdaq with the ticker symbol MTVA."
datetime: "2026-06-17T12:33:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290055475.md)
  - [en](https://longbridge.com/en/news/290055475.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290055475.md)
generator: "portal-rs"
---

# MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum

A biotechnology company called MetaVia Inc., which focuses on transforming cardiometabolic diseases, revealed that its President and CEO, Hyung Heon Kim, is set to take part in a fireside chat. The company made this announcement today in Cambridge, Mass., dated June 17, 2026. MetaVia Inc. is listed on Nasdaq with the ticker symbol MTVA.

### Related Stocks

- [MTVA.US](https://longbridge.com/en/quote/MTVA.US.md)

## Related News & Research

- [10:31 ETLiver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight](https://longbridge.com/en/news/296802956.md)
- [13:27 ETPatients Representing the Power of Advanced Therapies to Take Center Stage at Emily Whitehead Foundation's 2026 Believe Ball](https://longbridge.com/en/news/297074492.md)
- [Can Komzifti's Early Adoption Support Kura Oncology's Next Phase Of Growth?](https://longbridge.com/en/news/296928079.md)
- [Crosspoint Associates acquires Newton Corner retail property in Newton, Massachusetts](https://longbridge.com/en/news/296989392.md)
- [Bausch + Lomb Advancing Two First-In-Class Eye Health Therapies Based On Trial Results](https://longbridge.com/en/news/296827543.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**